RNF152
Basic information
Region (hg38): 18:61808067-61894247
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF152 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 16 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 0 | 0 |
Variants in RNF152
This is a list of pathogenic ClinVar variants found in the RNF152 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-61815932-C-T | not specified | Uncertain significance (Feb 12, 2024) | ||
18-61815986-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
18-61815992-G-A | not specified | Uncertain significance (Jul 14, 2022) | ||
18-61815995-T-C | not specified | Uncertain significance (Oct 12, 2021) | ||
18-61816039-A-G | not specified | Uncertain significance (Sep 16, 2021) | ||
18-61816067-C-A | not specified | Uncertain significance (Apr 18, 2023) | ||
18-61816102-A-G | not specified | Uncertain significance (Apr 18, 2023) | ||
18-61816135-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
18-61816157-G-T | not specified | Uncertain significance (Apr 07, 2023) | ||
18-61816162-A-G | not specified | Uncertain significance (Jul 09, 2021) | ||
18-61816190-T-C | not specified | Uncertain significance (Mar 07, 2024) | ||
18-61816219-G-A | not specified | Uncertain significance (Apr 09, 2024) | ||
18-61816251-G-A | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
18-61816268-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
18-61816277-C-T | not specified | Uncertain significance (Dec 01, 2023) | ||
18-61816298-C-T | not specified | Uncertain significance (Oct 06, 2023) | ||
18-61816301-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
18-61816400-G-A | not specified | Uncertain significance (Apr 17, 2023) | ||
18-61816403-G-A | not specified | Uncertain significance (Apr 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RNF152 | protein_coding | protein_coding | ENST00000312828 | 1 | 86185 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.129 | 0.788 | 125730 | 0 | 11 | 125741 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.648 | 116 | 137 | 0.844 | 0.00000919 | 1307 |
Missense in Polyphen | 50 | 64.181 | 0.77905 | 592 | ||
Synonymous | 0.715 | 55 | 62.2 | 0.885 | 0.00000450 | 437 |
Loss of Function | 1.39 | 2 | 5.53 | 0.362 | 2.37e-7 | 61 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000206 | 0.000206 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase mediating 'Lys-63'-linked polyubiquitination of RRAGA in response to amino acid starvation. Thereby, regulates mTORC1 signaling and plays a role in the cellular response to amino acid availability (PubMed:25936802). Also mediates 'Lys-48'-linked polyubiquitination of target proteins and their subsequent targeting to the proteasome for degradation. Induces apoptosis when overexpressed (PubMed:21203937). {ECO:0000269|PubMed:21203937, ECO:0000269|PubMed:25936802}.;
- Pathway
- mTOR signaling pathway - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
(Consensus)
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- loftool
- 0.218
- rvis_EVS
- -0.09
- rvis_percentile_EVS
- 46.74
Haploinsufficiency Scores
- pHI
- 0.708
- hipred
- N
- hipred_score
- 0.383
- ghis
- 0.513
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.906
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnf152
- Phenotype
Zebrafish Information Network
- Gene name
- rnf152
- Affected structure
- neural tube
- Phenotype tag
- abnormal
- Phenotype quality
- decreased width
Gene ontology
- Biological process
- apoptotic process;positive regulation of autophagy;protein ubiquitination;cellular response to amino acid starvation;protein K63-linked ubiquitination;protein K48-linked ubiquitination;negative regulation of TORC1 signaling
- Cellular component
- lysosome;lysosomal membrane;integral component of organelle membrane
- Molecular function
- ubiquitin-protein transferase activity;small GTPase binding;metal ion binding;ubiquitin protein ligase activity